Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group

A Benard, A van Sighem, A Taieb, E Valadas, V Soriano, A Calmy, C Balotta, F Damond, F Brun-Vezinet, G Chene, S Matheron, The ACHIEV2E Collaboration Study Group

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1257-1266
Number of pages10
JournalClinical Infectious Diseases
Volume52
Publication statusPublished - 2011
Externally publishedYes

Cite this